Acquisition momentum ASP has recent M&A activity including acquiring UV Smart and forming strategic partnerships, signaling a growth trajectory and potential cross-sell opportunities across sterilization and disinfection product lines.

Expansion partnerships Strategic partnerships with ChemDAQ and a Sterilization Assurance agreement with Premier, Inc. create channels for joint offerings, compliance support, and expanded procurement reach into healthcare networks.

Innovative sterilization Launches like the 68-minute Sterilizable DEC Duodenoscope and BIOTRACE Instant Read Steam System indicate a focus on faster, data-driven sterilization and reusable devices, opening upsell potential to facilities seeking efficiency and traceability.

Sustainability edge Environmental recognition and sustainable sterilization technologies position ASP to penetrate sustainability-focused buyers and hospital committees evaluating greener infection control solutions.

Data driven safety Adoption of technologies such as Power BI and Dynatrace, along with real-time sterility data capabilities, enables value propositions around operational visibility, compliance, and faster decision cycles for infection prevention programs.